Real-time enrollment status for this i cannot determine a primary medical condition from the provided information. the study appears to be testing an mri contrast agent, but no specific medical condition or patient population is indicated in the available data. clinical trial
Current Status
Completed
Checked: March 2, 2026 at 10:10 AM UTC
| NCT Number | NCT06322342 |
| Recruiting Status | Completed |
| Condition | I cannot determine a primary medical condition from the provided information. The study appears to be testing an MRI contrast agent, but no specific medical condition or patient population is indicated in the available data. |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Reveal Pharmaceuticals Inc. |
| Last Updated on CT.gov | December 26, 2025 (Dec 26, 2025) |
As of March 2, 2026: Clinical trial NCT06322342 is currently completed participants. This clinical trial study for i cannot determine a primary medical condition from the provided information. the study appears to be testing an mri contrast agent, but no specific medical condition or patient population is indicated in the available data. is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Reveal Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06322342 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06322342 was last updated Dec 26, 2025 (December 26, 2025). HelloStudys verifies this status automatically.